author-photo

D. Chand

University of Gothenburg

3

Papers

101

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN.

2016 Disease Models & Mechanisms
Show All
- Source
- Cite
- Save
Citations (56)
PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.

2016 Oncogene
Show All
- Source
- Cite
- Save
Citations (45)
Abstract B12: The ALK inhibitor PF-06463922 shows significant response as a single agent in ALK/MYCN driven models of neuroblastoma

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)